Filing Details

Accession Number:
0001104659-21-047253
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-04-06 21:56:16
Reporting Period:
2021-04-05
Accepted Time:
2021-04-06 21:56:16
Original Submission Date:
2021-04-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818844 Virios Therapeutics Inc. VIRI Pharmaceutical Preparations (2834) 854314201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831127 Scott Gregory Duncan C/O Virios Therapeutics, Inc.
44 Milton Avenue
Alpharetta GA 30009
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-05 15,675 $6.17 19,579 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.